Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
14.45
-0.39 (-2.63%)
At close: May 12, 2025, 4:00 PM
14.39
-0.06 (-0.42%)
After-hours: May 12, 2025, 4:24 PM EDT
Delcath Systems Market Cap
Delcath Systems has a market cap or net worth of $483.16 million as of May 12, 2025. Its market cap has increased by 260.84% in one year.
Market Cap
483.16M
Enterprise Value
425.28M
1-Year Change
260.84%
Ranking
Category
Stock Price
$14.45
Market Cap Chart
Since May 10, 2018, Delcath Systems's market cap has increased from $2.70M to $483.16M, an increase of 17,794.78%. That is a compound annual growth rate of 109.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 516.80M | 34.23% |
| Dec 31, 2024 | 385.00M | 319.85% |
| Dec 29, 2023 | 91.70M | 195.81% |
| Dec 30, 2022 | 31.00M | -45.61% |
| Dec 31, 2021 | 57.00M | -22.76% |
| Dec 31, 2020 | 73.80M | 9,125.00% |
| Dec 31, 2019 | 800.00K | -68.00% |
| Dec 31, 2018 | 2.50M | -7.41% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |